NuVasive | NUVA - SCHULD



SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
AtriCure USD 76.73M 521K 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cooper Companies USD 2.51B 27M 2025-09
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 600M 105.4M 2026-03
Globus Medical USD 119.34M 1.76M 2025-09
Haemonetics USD 1.22B 54K 2025-09
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intuitive Surgical USD 0 0 2025-03
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.15M 599K 2025-09
Orthofix International USD 137.23M 338K 2024-09
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12